| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,717 |
1,345 |
$92K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,809 |
1,365 |
$70K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
327 |
263 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
521 |
413 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
75 |
59 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
36 |
27 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
204 |
98 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
193 |
153 |
$2K |
| 99336 |
|
37 |
37 |
$2K |
| 92551 |
|
72 |
51 |
$392.13 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
36 |
28 |
$226.81 |
| 80305 |
|
31 |
23 |
$179.82 |
| 36415 |
Collection of venous blood by venipuncture |
129 |
122 |
$151.41 |
| 99173 |
|
70 |
50 |
$146.56 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
112 |
84 |
$102.93 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22 |
12 |
$82.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
69 |
58 |
$20.30 |
| 94760 |
|
25 |
22 |
$1.55 |